Neuro Strengths-Based Approach to Autism (NSBAA)

February 21, 2023 updated by: Baio Enterprises

Training in Neuro Strengths-Based Approach to Autism

The Neuro-Strength-Based Approach to Autism (NSBAA) attempts to translate what research has discovered about the autistic brain into terms that autistics, and those involved with autistics, can understand. It is not intended to be a new approach to intervention but hopefully a unifying approach to understanding autism that all therapists, educators, clinicians, and parents can use when working with autistic individuals. It was developed by an autistic occupational therapist, based on her lifetime obsession of learning everything she could about how typical brains work, and, following her diagnosis, how the autistic brain works. Being on the autism spectrum herself and having worked with, and interacted with, autistic individuals of all ages and abilities in school, clinical, and personal settings, the author attempts to explain the autistic brain from both the scientific as well as autistic perspectives.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

16

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Colorado
      • Littleton, Colorado, United States, 80123
        • Staci L Neustadt

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 5-20 SLPs / OTR/Ls, regardless of nationality
  • working in a clinical, home or school setting with less than 25 years of experience
  • at least 2 years of experience working with autistic clients

Exclusion Criteria:

  • Minors
  • adults unable to consent
  • undocumented individuals
  • prisoners,
  • uncertified therapists
  • therapists from Baio Enterprises.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: NSBAA
The Neuro Strengths-Base Approach to Autism is an approach developed from various research on how the autistic brain works, the approaches that work best to motivate autistic individuals, and how others can understand as well as support behaviors that may occur with autistic individuals.
Behavioral: NSBAA
The Neuro Strengths-Based Approach to Autism is an approach that teaches people how the autistic brain works and the best practices for providing intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measurable change in the participant's satisfaction with their ability to write neuro-strength-based goals
Time Frame: After 16 hours of training
Participants will show a significant increase (50% or higher) in their ratings on the NSBSA Satisfaction With Writing and Implementing Goals For Autistic Clients given to them pre-training, 3 months post-training, and 6 months post-training. They will rate their satisfaction with 28 elements included in the NSBSA Training Modules using a rating scale of 1-5, with 1 being very dissatisfied and 5 being very satisfied. The highest possible score is 140 and the lowest is 28.
After 16 hours of training
Measurable change in participants' knowledge of the clinical reasoning for the goals they write
Time Frame: After 16 hours of training
Participants will show a significant increase (50% or higher) in the number of goal components they are able to include in their goal, with a maximum of 8, and the number of questions that challenge their reasoning for what they include, with a maximum of 23, in the goals they submit using the Pre- and Post-Training Goal Writing Forms. The highest possible score is 31 if they complete all components and answer all questions. The lowest possible score is 0.
After 16 hours of training

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measurable change in the completeness of the goals:
Time Frame: After 16 hours of training
Participants will show a significant increase (50% or higher) in the score they receive on the Post-Training Goal Writing Form compared to the Pre-Training Goal Writing Form, using the Pre-and Post-Training Scoring for Goal Writing Form, with the highest possible score being +32 and the lowest score being -16 with an average score of 0.
After 16 hours of training

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Baio Enterprises

Collaborators

Baio Institute

Investigators

  • Principal Investigator: Blair Braden, PhD, Arizona State University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 4, 2022

Primary Completion (Actual)

December 13, 2022

Study Completion (Anticipated)

July 30, 2023

Study Registration Dates

First Submitted

July 18, 2022

First Submitted That Met QC Criteria

August 10, 2022

First Posted (Actual)

August 12, 2022

Study Record Updates

Last Update Posted (Estimate)

February 22, 2023

Last Update Submitted That Met QC Criteria

February 21, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • STUDY00015835

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe